Citurgia Biochemicals Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Selling, General & Admin	1.39	1.69	1.69	1.62	1.6	1.4
Other Operating Expenses	0.25	0.28	0.81	0.48	0.19	2.33
Operating Expenses	3.89	4.23	4.76	4.36	4.04	6.12
Operating Income	-3.89	-4.23	-4.76	-4.36	-4.04	-6.12
Interest Expense	-0	-0	-0	-0	-0	-0
Pretax Income	-3.89	-4.23	-4.76	-4.36	-4.04	-6.12
Net Income	-3.89	-4.23	-4.76	-4.36	-4.04	-6.12
Net Income to Common	-3.89	-4.23	-4.76	-4.36	-4.04	-6.12
Shares Outstanding (Basic)	-	132	132	132	132	132
Shares Outstanding (Diluted)	-	132	132	132	132	132
EPS (Basic)	-	-0.03	-0.04	-0.03	-0.03	-0.05
EPS (Diluted)	-	-0.03	-0.04	-0.03	-0.03	-0.05
EBITDA	-1.64	-1.97	-2.5	-2.1	-1.78	-3.73
D&A For EBITDA	2.26	2.26	2.26	2.26	2.26	2.39
EBIT	-3.89	-4.23	-4.76	-4.36	-4.04	-6.12
Advertising Expenses	-	-	-	-	0.01	0.03

Source: S&P Global Market Intelligence. Standard template. Financial Sources.